Thailand's nasal spray new crown vaccine is expected to enter clinical trials by the end of the year

Xinhua News Agency, Bangkok, August 11 (Ren Qian) The National Science and Technology Development Agency of Thailand recently announced that the two nasal spray vaccines developed by the agency against the new coronavirus are expected to enter phase I clinical trials by the end of this year
.

The National Science and Technology Development Agency of Thailand said in a statement on the 10th that the two nasal spray new crown vaccines independently developed by the National Genetic Engineering and Biotechnology Research Center under the agency have now completed the animal experiment stage and have good results.
They will be sent to Thailand in the near future.
The Food and Drug Administration of the Ministry of Health applied for clinical trials
.

The research center's vaccine research director Anan Kewatana said that the two nasal spray vaccines are adenovirus vector vaccines and attenuated influenza virus vector vaccines
.

Anan also said that the researchers will also test the effectiveness of the two vaccines against the Delta strain.